Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Harm prevalence due to medication errors involving high-alert medications: a systematic review

Sodré Alves BMC, de Andrade TNG, Cerqueira Santos S, et al. Harm prevalence due to medication errors involving high-alert medications: a systematic review. J Patient Saf. 2021;17(1):e1-e9. doi:10.1097/pts.0000000000000649.

Save
Print
May 20, 2020
Sodré Alves BMC, de Andrade TNG, Cerqueira Santos S, et al. J Patient Saf. 2021;17(1):e1-e9.
View more articles from the same authors.

This systematic review analyzed five studies discussing adverse events due to medical errors involving high-alert medications. The authors estimated the pooled prevalence at 16.3%, but the included studies reported a wide variation in prevalence (from 3.8% to 100%). The studies also reported a wide range in error severity – up to 19.2% were considered moderate, up to 15.4% were considered serious, and up to 1.9% were considered lethal. The most common medication administration errors involved insulin, potassium chloride, and epoprostenol.

Save
Print
Cite
Citation

Sodré Alves BMC, de Andrade TNG, Cerqueira Santos S, et al. Harm prevalence due to medication errors involving high-alert medications: a systematic review. J Patient Saf. 2021;17(1):e1-e9. doi:10.1097/pts.0000000000000649.